Applied DNA Sciences (NASDAQ:APDN – Get Free Report) will likely be releasing its earnings data before the market opens on Thursday, February 13th. Analysts expect Applied DNA Sciences to post earnings of ($0.32) per share and revenue of $1.18 million for the quarter.
Applied DNA Sciences (NASDAQ:APDN – Get Free Report) last posted its quarterly earnings data on Tuesday, December 17th. The technology company reported ($0.32) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.01. Applied DNA Sciences had a negative return on equity of 111.18% and a negative net margin of 203.76%.
Applied DNA Sciences Price Performance
NASDAQ:APDN opened at $0.18 on Wednesday. The company has a market capitalization of $10.09 million, a P/E ratio of -0.03 and a beta of 0.37. The business has a fifty day simple moving average of $0.19 and a two-hundred day simple moving average of $0.53. Applied DNA Sciences has a 1 year low of $0.12 and a 1 year high of $14.40.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
See Also
- Five stocks we like better than Applied DNA Sciences
- The Basics of Support and Resistance
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- How to Invest in Blue Chip Stocks
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.